FDA data Registry peer set 1 peer

Alternatives to vibegron

1 same-class SPL records vs vibegron - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Gems

Beta-3 Agonist (Overactive Bladder) Prescription 1 alternative found

About vibegron

Gemtesa is a medicine that helps control an overactive bladder. It relaxes the bladder muscle, so you don't have to go to the bathroom as often.

Used for: Gemtesa treats overactive bladder (OAB) in adults. OAB can cause you to feel a sudden need to pee (urgency). It can also cause you to pee more often (frequency) or leak urine (urge urinary incontinence). Gemtesa can also treat these symptoms in men who are taking medicine for an enlarged prostate (benign prostatic hyperplasia or BPH).

1 Beta-3 Agonist (Overactive Bladder) peers (wide set)

Compare vibegron vs mirabegron side-by-side →

vibegron vs mirabegron · FAERS reaction fields

FAERS top-reaction field "Headache" shows the widest count spread between vibegron and mirabegron in this extract (1,834-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect vibegron mirabegron
Diarrhoea 328 1,861
Headache 328 2,162
Urinary Tract Infection 280 -
Inability To Afford Medication 265 -
Urinary Retention 258 -
Fatigue 248 2,215
Nausea 219 1,705
Death 205 -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

vibegron peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for Beta-3 Agonist (Overactive Bladder): 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside vibegron?
This registry lists 1 Beta-3 Agonist (Overactive Bladder) medication records beside vibegron, including mirabegron. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Beta-3 Agonist (Overactive Bladder) peer set (1 records)

vibegron (Gems) sits in a wide Beta-3 Agonist (Overactive Bladder) peer set (1 of 1 class peers shown). Labeled indication field for vibegron: Gemtesa treats overactive bladder (OAB) in adults.

Top FAERS reaction fields for vibegron total 2,529 reports across 10 reactions, set beside mirabegron. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full vibegron profile →

Field note for vibegron: see also the generic vs brand label guide when reading Gems SPL strings.